Prehabilitation for Cardiac Surgery in Patients With Reduced Exercise Tolerance
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04545268|
Recruitment Status : Recruiting
First Posted : September 10, 2020
Last Update Posted : September 10, 2020
Among patients awaiting cardiac surgery, a significant proportion are patients with severe angina, heart failure (HF) and peripheral atherosclerosis. These factors are predictors of an unfavorable near and long-term prognosis after open cardiac surgery. It is known that the restriction of motor activity in patients with peripheral atherosclerosis and HF leads to loss of muscle mass, as well as to a decrease in its strength and endurance: secondary (disuse) sarcopenia is formed. In patients with peripheral atherosclerosis and HF, the low functional status of skeletal muscles is associated with a poor prognosis, regardless of gender, age, and concomitant coronary artery disease. A number of studies have shown that the deterioration of muscle status before abdominal, orthopedic and vascular surgery interferes with the close results of surgery, increases the number of complications, the length of ICU and in-hospital stay. Thus, sarcopenia serves as an additional factor worsening the prognosis. Therefore, efforts aimed at improving the functional status in patients planning an open cardiosurgical surgery seem to be very justified.
Standard preoperative management of patients includes the identification and correction of comorbidities and the optimal medical treatment. The idea of "rehabilitation" means an additional improvement in the functional capabilities of patients awaiting surgery. Prevention includes outpatient outreach and educational work by nurses, as well as preoperative physical exercises. For this, multi-level training is used: respiratory exercises for the patients with the most severe illness, free movements of the limbs without load, or bike or treadmill training with increasing load for tolerable patients.
However, adequate physical rehabilitation is difficult particularly on an outpatient basis. Low adherence is due in part to inadequate strength and inability to tolerate or sustain even low levels of activity due to angina, chronic lower limb ischemia and heart failure symptoms.
In this study, the investigators propose to use neuromuscular electrical stimulation (NMES) to assist patient initiation of quadriceps strengthening in order to progressively increase low exercise tolerance.
|Condition or disease||Intervention/treatment||Phase|
|Sarcopenia Exercise Intolerance Heart Failure Peripheral Artery Disease||Device: Neuromuscular electrical stimulation (NMES) Device: Transcutaneous electrical stimulation||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||60 participants|
|Intervention Model:||Parallel Assignment|
|Intervention Model Description:||This is a single-blinded, randomized controlled longitudinal study design to determine if NMES will increase muscle mass and strength and improve exercise capacity thus improving likelihood of engagement with a structured exercise program. Patients will be randomized to either intervention that includes NMES or to a sham control group. In order to ensure that the two groups are comparable between treatment and sham interventions, the participants will be randomized according to gender. Randomization via minimization will be used in order to avoid an unbalanced number of women in the two comparison groups due to chance. A file of the computer-generated random assignments will be kept.|
|Masking:||Single (Outcomes Assessor)|
|Masking Description:||The Investigator will collect baseline data before the participant is randomized. The intervention/sham will be set-up by the Investigator. The Investigator who is trained in both NMES and Sham intervention will then look at the randomization schedule and set up and train the participants on equipment use|
|Official Title:||Prehabilitation for Cardiac Surgery in Patients With Reduced Exercise Tolerance|
|Estimated Study Start Date :||September 2020|
|Estimated Primary Completion Date :||August 2022|
|Estimated Study Completion Date :||December 2022|
|Sham Comparator: Control group||
Device: Transcutaneous electrical stimulation
For the Sham group, electrodes will follow the same site, but the stimulation will only increase to an intermittent tingling sensation with the machine setting on TENS instead of NMES which is not enough to make noticeable changes in muscle mass or circulation. Intensity settings will not change over time.
|Experimental: NMES group||
Device: Neuromuscular electrical stimulation (NMES)
NMES will carried out with four-channel myostimulator "Beurer EM80" (Germany). Self-adhesive electrodes locates above the quadriceps, the duration of the NMES session was 60 minutes, including 5-minute periods of heating and hitch. Throughout the series, rectangular pulses with a frequency of 45 Hz will modulate. As a result, tonic contraction of these muscles will induce for 12 seconds, followed by a pause of 5 seconds. The amplitude of electrical exposure will select separately for each of the four channels until good muscle contraction (visually or by palpation) without pain. Electrical stimulation will start from the second day after the admission to preoperative department and will carried out during the entire preoperative period (about 10 days).
- Change in strength test (Dynamometer) from baseline to post EMS in EMS vs. controls [ Time Frame: From baseline to post EMS (at least 6th day after baseline) ]Strength Assessment using a portable hand-held dynamometer (Lafayette Manual Muscle Test System 001165)
- Change in strength test (Dynamometer) from post EMS to pre-discharge in EMS vs. controls [ Time Frame: from post EMS (at least 6th day after baseline) to the end of hospitalisation (expected an average of 10 days) ]Strength Assessment will be done using a portable hand-held dynamometer (Lafayette Manual Muscle Test System 001165).
- Change in 6-minute walk test distance from baseline to post EMS in EMS vs. controls [ Time Frame: Baseline, post EMS (at least 6th day after baseline) ]Participants will be instructed to move as quickly as they feel safe and comfortable over the 50-meter course for 6 minutes. As per the protocol, participants will be allowed to stop and rest if necessary
- Change in 6-minute walk test distance from post EMS to pre-discharge in EMS vs. controls [ Time Frame: Baseline, post EMS (at least 6th day after baseline) ]Participants will be instructed to move as quickly as they feel safe and comfortable over the 50-meter course for 6 minutes. As per the protocol, participants will be allowed to stop and rest if necessary
- Change in length of stay (LOS) in ICU in EMS vs. controls. [ Time Frame: From the end of cardiac procedure to the end of ICU stay (expected an average of 1 day) ]
- Change in length of stay (LOS) in postoperative department in EMS vs. controls [ Time Frame: From the end of cardiac procedure to the end of hospitalisation (expected an average of 10 days) ]number of days
- Change in mechanical ventilation duration in EMS vs. controls [ Time Frame: from the intubation to the extubation (expected an average of 7 hours) ]number of minuits
- Rate of postoperative complication or death [ Time Frame: From the end of cardiac procedure to the end of hospitalisation (expected an average of 10 days) ]Any complication wich required hospitalisation prolongation or additional procedures (eg pleural or pericardial punction, renal replacemen therapy, pneumonia, wound complications etc.) or death
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04545268
|Contact: Andrey V Bezdenezhnykh, PhDemail@example.com|
|Research Institute for Complex Issues of Cardiovascular Diseases||Recruiting|
|Kemerovo, Russian Federation, 650002|
|Contact: Andrew V Bezdenezhnykh, PhD +79132971069 firstname.lastname@example.org|
|Principal Investigator:||Andrey V Bezdenezhnykh, PhD||Research Institute for Complex Issues of Cardiovacular Diseases|